Amneal pharmaceuticals inc

NA

AMRX


400 Crossing Boulevard
Bridgewater , NJ 08807

Executive/
Director

Price

  • Last Close
  • $ 7.82
    $ +0.07 0.84 %
    Jan 3, 2025
  • 52-Week High/Low
  • $8.68 - $3.37
  • YTD
  • -1.4%

  • Trading Volume
  • 38,032
  • Market Cap Full
  • $ 7.8K
  • Shares Outstanding
  • 0M
    May 7, 2018
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 4.7% -5% 45.4% -12.9% -29.9% -0.2% -1.4%
Q2 -80% -80% 9.3% -48.9% 4% -23% -23.7% 122.9% -0.5% -
Q3 -80% -80% 34.4% -59.9% 8% 4.3% -36.5% 35.4% 18.3% -
Q4 -80% -80% -37% 59.4% 17.8% -10.3% -1.5% 42% -2% -
J F M A M J J A S O N D
2025 -1.4% - - - - - - - - - - -
2024 -11.9% 3.2% 9.8% -0.7% - - - 18.3% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%-65%-3%5%-58%205%31%-1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -1.81 -0.37 0.78 0.04 -0.01 -0.05
Q2 - - -0.15 -0.13 -0.08 0.1 -0.8 0.08
Q3 - - 0.05 -2.03 -0.06 -0.03 -0.02 0.06
Q4 - - 1.75 -0.21 -0.03 -0.04 -0.03 -
A 0 0 -0.2 -2.7 0.6 0.1 -0.9 0.09

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018
Mar -
Jun 0
Sep -
Dec -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.7 2.7 2.8 3.3 2.1
Fixed Asset Turnover 3.9 3.9 3.9 3.1 2.7
Total Asset Turnover 0.6 0.5 0.5 0.4 0.4
Leverage
Debt Ratio 1.9 1.8 1.8 2.2 2
Debt – Equity Ratio 14.3 7.4 8 7.5 2.9
Interest Coverage -2.7 1.1 - -2.2 -0.1
Equity multiplier 3.1 1.5 1.5 1.5 0.7